Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242

1.

Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension.

Young A, Nagaraja V, Basilious M, Habib M, Townsend W, Gladue H, Badesch D, Gibbs JSR, Gopalan D, Manes A, Oudiz R, Satoh T, Torbicki A, Torres F, McLaughlin V, Khanna D.

Semin Arthritis Rheum. 2018 Oct 14. pii: S0049-0172(18)30446-3. doi: 10.1016/j.semarthrit.2018.10.010. [Epub ahead of print]

PMID:
30415942
2.

Response to letter from dr Altmayer regarding publication "Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics".

Darocha S, Banaszkiewicz M, Pietrasik A, Piłka M, Florczyk M, Wieteska M, Dobosiewicz A, Szmit S, Torbicki A, Kurzyna M.

Int J Cardiol. 2018 Oct 30. pii: S0167-5273(18)35723-1. doi: 10.1016/j.ijcard.2018.10.103. [Epub ahead of print] No abstract available.

PMID:
30414750
3.

Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy.

Araszkiewicz A, Darocha S, Pietrasik A, Pietura R, Jankiewicz S, Banaszkiewicz M, Sławek-Szmyt S, Biederman A, Mularek-Kubzdela T, Lesiak M, Torbicki A, Kurzyna M.

Int J Cardiol. 2018 Oct 25. pii: S0167-5273(18)33706-9. doi: 10.1016/j.ijcard.2018.10.066. [Epub ahead of print]

PMID:
30409735
4.

Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study.

Agnelli G, Becattini C, Bauersachs R, Brenner B, Campanini M, Cohen A, Connors JM, Fontanella A, Gussoni G, Huisman MV, Lambert C, Meyer G, Muñoz A, Abreu de Sousa J, Torbicki A, Verso M, Vescovo G; Caravaggio Study Investigators.

Thromb Haemost. 2018 Sep;118(9):1668-1678. doi: 10.1055/s-0038-1668523. Epub 2018 Aug 13.

PMID:
30103252
5.

Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics.

Darocha S, Banaszkiewicz M, Pietrasik A, Piłka M, Florczyk M, Wieteska M, Dobosiewicz A, Szmit S, Torbicki A, Kurzyna M.

Int J Cardiol. 2018 Oct 15;269:283-288. doi: 10.1016/j.ijcard.2018.07.015. Epub 2018 Jul 3.

PMID:
30017517
6.

Pregnancy as a predictor of deviations from the recommended diagnostic pathway in women with suspected pulmonary embolism: ZATPOL registry data.

Fijałkowska A, Szczerba E, Szewczyk G, Budaj-Fidecka A, Burakowski J, Sobkowicz B, Nowowiejska-Wiewióra A, Opolski G, Torbicki A, Kurzyna M; Investigators ZATPOL Registry.

Arch Med Sci. 2018 Jun;14(4):838-845. doi: 10.5114/aoms.2017.70896. Epub 2017 Oct 20.

7.

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial.

Souza R, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun FO, Mehta S, Perchenet L, Pulido T, Sastry BKS, Sitbon O, Torbicki A, Rubin LJ, Simonneau G.

PLoS One. 2018 Mar 28;13(3):e0193226. doi: 10.1371/journal.pone.0193226. eCollection 2018.

8.

Determinants of Survival After Emergency Intrapericardial Cisplatin Treatment in Cancer Patients with Recurrent Hemodynamic Instability After Pericardiocentesis.

Darocha S, Wilk M, Walaszkowska-Czyż A, Kępski J, Mańczak R, Kurzyna M, Torbicki A, Szmit S.

In Vivo. 2018 Mar-Apr;32(2):373-379.

9.

Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.

McLaughlin VV, Hoeper MM, Channick RN, Chin KM, Delcroix M, Gaine S, Ghofrani HA, Jansa P, Lang IM, Mehta S, Pulido T, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A, Tapson VF, Perchenet L, Preiss R, Verweij P, Rubin LJ, Galiè N.

J Am Coll Cardiol. 2018 Feb 20;71(7):752-763. doi: 10.1016/j.jacc.2017.12.010.

10.

The importance of psychosocial factors in management of pulmonary arterial hypertension patients.

Sobczak-Kaleta MA, Torbicki A, Kasprzak JD.

Kardiol Pol. 2018;76(3):529-535. doi: 10.5603/KP.a2018.0029. Epub 2018 Jan 19. No abstract available.

11.

Acute and chronic dissection of pulmonary artery: new challenges in pulmonary arterial hypertension?

Florczyk M, Wieteska M, Kurzyna M, Gościniak P, Pepke-Żaba J, Biederman A, Torbicki A.

Pulm Circ. 2018 Apr-Jun;8(2):2045893217749114. doi: 10.1177/2045893217749114. Epub 2017 Dec 18.

12.

An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil.

Kurzyna M, Małaczyńska-Rajpold K, Koteja A, Pawlak A, Chrzanowski Ł, Furdal M, Gąsior Z, Jacheć W, Sobkowicz B, Norwa J, Mularek-Kubzdela T, Torbicki A.

BMC Pulm Med. 2017 Dec 2;17(1):162. doi: 10.1186/s12890-017-0474-7.

13.

Sarcoidosis-associated pulmonary hypertension treated with sildenafil - a case report.

Kacprzak A, Szturmowicz M, Burakowska B, Franczuk M, Kober J, Kurzyna M, Wilk M, Szmit S, Torbicki A, Kuś J.

Adv Respir Med. 2017;85(5):258-263. doi: 10.5603/ARM.a2017.0042. Epub 2017 Oct 30.

14.

Macitentan for treatment of CTEPH: why MERIT merits attention.

Torbicki A.

Lancet Respir Med. 2017 Oct;5(10):762-763. doi: 10.1016/S2213-2600(17)30342-9. Epub 2017 Sep 11. No abstract available. Erratum in: Lancet Respir Med. 2017 Oct;5(10 ):e30.

PMID:
28919198
15.

Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, Document Reviewers, Widimsky P, Kolh P, Agewall S, Bueno H, Coca A, De Borst GJ, Delgado V, Dick F, Erol C, Ferrini M, Kakkos S, Katus HA, Knuuti J, Lindholt J, Mattle H, Pieniazek P, Piepoli MF, Scheinert D, Sievert H, Simpson I, Sulzenko J, Tamargo J, Tokgozoglu L, Torbicki A, Tsakountakis N, Tuñón J, de Ceniga MV, Windecker S, Zamorano JL.

Eur J Vasc Endovasc Surg. 2018 Mar;55(3):305-368. doi: 10.1016/j.ejvs.2017.07.018. Epub 2017 Aug 26. No abstract available.

PMID:
28851596
16.

Contemporary methods for the treatment of pulmonary embolism - is it prime-time for percutaneous interventions?

Kurzyna M, Pietrasik A, Opolski G, Torbicki A.

Kardiol Pol. 2017;75(11):1161-1170. doi: 10.5603/KP.a2017.0125. Epub 2017 Jul 17. Review. No abstract available.

17.

[A statement the Polish Cardiac Society Working Group on Pulmonary Circulation on screening for CTEPH patients after acute pulmonary embolism].

Ciurzyński M, Kurzyna M, Kopeć G, Błaszczak P, Chrzanowski Ł, Kamiński K, Mizia-Stec K, Mularek-Kubzdela T, Mroczek E, Biederman A, Pruszczyk P, Torbicki A.

Kardiol Pol. 2017;75(6):620-627. doi: 10.5603/KP.2017.0110. Polish.

PMID:
28628189
18.

Changing the strategy of balloon pulmonary angioplasty resulted in a reduced complication rate in patients with chronic thromboembolic pulmonary hypertension. A single-centre European experience.

Kurzyna M, Darocha S, Pietura R, Pietrasik A, Norwa J, Mańczak R, Wieteska M, Biederman A, Matsubara H, Torbicki A.

Kardiol Pol. 2017;75(7):645-654. doi: 10.5603/KP.a2017.0091. Epub 2017 May 29.

19.

The pathophysiology of chronic thromboembolic pulmonary hypertension.

Simonneau G, Torbicki A, Dorfmüller P, Kim N.

Eur Respir Rev. 2017 Mar 29;26(143). pii: 160112. doi: 10.1183/16000617.0112-2016. Print 2017 Mar 31. Review.

20.

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.

Galiè N, Jansa P, Pulido T, Channick RN, Delcroix M, Ghofrani HA, Le Brun FO, Mehta S, Perchenet L, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A.

Eur Heart J. 2017 Apr 14;38(15):1147-1155. doi: 10.1093/eurheartj/ehx025.

21.

Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function.

Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, Brekelmans MP, Büller HR, Elias A, Farge D, Konstantinides S, Palareti G, Prandoni P, Righini M, Torbicki A, Vlachopoulos C, Brodmann M.

Eur Heart J. 2017 Feb 17. doi: 10.1093/eurheartj/ehx003. [Epub ahead of print] No abstract available.

PMID:
28329262
22.

Improvement in Quality of Life and Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension Treated With Balloon Pulmonary Angioplasty.

Darocha S, Pietura R, Pietrasik A, Norwa J, Dobosiewicz A, Piłka M, Florczyk M, Biederman A, Torbicki A, Kurzyna M.

Circ J. 2017 Mar 24;81(4):552-557. doi: 10.1253/circj.CJ-16-1075. Epub 2017 Feb 1.

23.

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.

Kim NH, D'Armini AM, Grimminger F, Grünig E, Hoeper MM, Jansa P, Mayer E, Neurohr C, Simonneau G, Torbicki A, Wang C, Fritsch A, Davie N, Ghofrani HA.

Heart. 2017 Apr;103(8):599-606. doi: 10.1136/heartjnl-2016-309621. Epub 2016 Dec 23.

24.

[2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines].

Zamorano JL, Lancellotti P, Muñoz DR, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GY, Lyon AR, Fernandez TL, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM.

Kardiol Pol. 2016;74(11):1193-1233. doi: 10.5603/KP.2016.0156. Polish. No abstract available.

25.

Prognostic Significance of Right Heart Thrombi in Patients With Acute Symptomatic Pulmonary Embolism: Systematic Review and Meta-analysis.

Barrios D, Rosa-Salazar V, Morillo R, Nieto R, Fernández S, Zamorano JL, Monreal M, Torbicki A, Yusen RD, Jiménez D.

Chest. 2017 Feb;151(2):409-416. doi: 10.1016/j.chest.2016.09.038. Epub 2016 Oct 14. Review.

PMID:
27746202
26.

The "bouncing" catheter.

Malaczynska-Rajpold K, Kurzyna M, Koteja A, Torbicki A, Mularek-Kubzdela T.

Cardiol J. 2016;23(5):552-553. doi: 10.5603/CJ.2016.0076. No abstract available.

27.

Centrilobular nodules in high resolution computed tomography of the lung in IPAH patients - preliminary data concerning clinico-radiological correlates.

Szturmowicz M, Kacprzak A, Burakowska B, Skoczylas A, Bestry I, Kuś J, Fijałkowska A, Torbicki A, Kurzyna M.

Pneumonol Alergol Pol. 2016;84(5):265-70. doi: 10.5603/PiAP.2016.0033.

28.

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.

Mehta S, Sastry BKS, Souza R, Torbicki A, Ghofrani HA, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O.

Chest. 2017 Jan;151(1):106-118. doi: 10.1016/j.chest.2016.08.1473. Epub 2016 Sep 23. Erratum in: Chest. 2018 May;153(5):1287.

29.

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM; ESC Scientific Document Group.

Eur Heart J. 2016 Sep 21;37(36):2768-2801. doi: 10.1093/eurheartj/ehw211. Epub 2016 Aug 26. No abstract available. Erratum in: Eur Heart J. 2016 Dec 24;:.

30.

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GY, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM, Zamorano JL, Aboyans V, Achenbach S, Agewall S, Badimon L, Barón-Esquivias G, Baumgartner H, Bax JJ, Bueno H, Carerj S, Dean V, Erol Ç, Fitzsimons D, Gaemperli O, Kirchhof P, Kolh P, Lancellotti P, Lip GY, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Roffi M, Torbicki A, Vaz Carneiro A, Windecker S; Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); Document Reviewers.

Eur J Heart Fail. 2017 Jan;19(1):9-42. doi: 10.1002/ejhf.654. Epub 2016 Aug 27. Review. No abstract available.

31.

Vena cava superior stenting for rescue treatment of critical stenosis related to progressing cancer disease.

Darocha S, Szmit S, Pietura R, Torbicki A, Kurzyna M.

Kardiol Pol. 2016;74(6):601. doi: 10.5603/KP.2016.0094. No abstract available.

32.

Low DLCO in idiopathic pulmonary arterial hypertension - clinical correlates and prognostic significance.

Szturmowicz M, Kacprzak A, Franczuk M, Burakowska B, Kurzyna M, Fijałkowska A, Skoczylas A, Wesołowski S, Kuś J, Torbicki A.

Pneumonol Alergol Pol. 2016;84(2):87-94. doi: 10.5603/PiAP.2016.0006.

33.

Hypertension: Definition of pulmonary hypertension challenged?

Torbicki A.

Nat Rev Cardiol. 2016 May;13(5):250-1. doi: 10.1038/nrcardio.2016.44. Epub 2016 Mar 24. No abstract available.

PMID:
27009424
34.

2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):177. doi: 10.1016/j.rec.2016.01.002. No abstract available.

PMID:
26837729
35.

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.

Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D'Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Jaïs X, Ambroz D, Treacy C, Morsolini M, Jenkins D, Lindner J, Dartevelle P, Mayer E, Simonneau G.

Circulation. 2016 Mar 1;133(9):859-71. doi: 10.1161/CIRCULATIONAHA.115.016522. Epub 2016 Jan 29.

PMID:
26826181
36.

Outcome of patients with right heart thrombi: the Right Heart Thrombi European Registry.

Koć M, Kostrubiec M, Elikowski W, Meneveau N, Lankeit M, Grifoni S, Kuch-Wocial A, Petris A, Zaborska B, Stefanović BS, Hugues T, Torbicki A, Konstantinides S, Pruszczyk P; RiHTER Investigators.

Eur Respir J. 2016 Mar;47(3):869-75. doi: 10.1183/13993003.00819-2015. Epub 2016 Jan 21.

37.

[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Kardiol Pol. 2015;73(12):1127-206. doi: 10.5603/KP.2015.0242. Polish. No abstract available.

38.

Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN.

Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun FO, Mehta S, Perchenet L, Pulido T, Sastry BK, Sitbon O, Souza R, Torbicki A, Rubin LJ.

Eur Respir J. 2015 Dec;46(6):1711-20. doi: 10.1183/13993003.00364-2015. Epub 2015 Oct 22.

39.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M; ESC Scientific Document Group .

Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29. No abstract available.

40.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29. Erratum in: Eur Respir J. 2015 Dec;46(6):1855-6.

41.

Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension.

Benza RL, Gomberg-Maitland M, Demarco T, Frost AE, Torbicki A, Langleben D, Pulido T, Correa-Jaque P, Passineau MJ, Wiener HW, Tamari M, Hirota T, Kubo M, Tiwari HK.

Am J Respir Crit Care Med. 2015 Dec 1;192(11):1345-54. doi: 10.1164/rccm.201501-0196OC.

42.

Functional class and type of pulmonary hypertension determinate severity of cardiac autonomic dysfunction assessed by heart rate variability and turbulence.

Bienias P, Ciurzynski M, Kostrubiec M, Rymarczyk Z, Kurzyna M, Korczak D, Roik M, Torbicki A, Fijalkowska A, Pruszczyk P.

Acta Cardiol. 2015 Jun;70(3):286-96.

PMID:
26226702
43.

Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism.

Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs J, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Authors/Task Force Members.

Eur Heart J. 2015 Oct 14;36(39):2642. doi: 10.1093/eurheartj/ehu479. Epub 2015 Jul 28. No abstract available.

PMID:
26224077
44.

Right ventricle in pulmonary hypertension: echocardiography strikes back?

Torbicki A.

Circ Cardiovasc Imaging. 2015 Jun;8(6). pii: e003518. doi: 10.1161/CIRCIMAGING.115.003518. No abstract available.

PMID:
26038433
45.

Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism.

Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs J, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Authors/Task Force Members.

Eur Heart J. 2015 Oct 14;36(39):2666. doi: 10.1093/eurheartj/ehv131. Epub 2015 Apr 20. No abstract available.

PMID:
25896079
46.

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Kurzyna M, Darocha S, Koteja A, Pietura R, Torbicki A.

Postepy Kardiol Interwencyjnej. 2015;11(1):1-4. doi: 10.5114/pwki.2015.49176. Epub 2015 Mar 6. No abstract available.

47.

[Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology].

Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ, Provencher S, Torbicki A, Voelkel NF, Hassoun PM.

Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:29-44. Turkish.

48.

Summary of recommendations for the haemodynamic and angiographic assessment of the pulmonary circulation. Joint statement of the Polish Cardiac Society's Working Group on Pulmonary Circulation and Association of Cardiovascular Interventions.

Kurzyna M, Araszkiewicz A, Błaszczak P, Grabka M, Hawranek M, Kopeć G, Mroczek E, Zembala M, Torbicki A, Ochała A.

Kardiol Pol. 2015;73(1):63-8. doi: 10.5603/KP.2015.0011.

PMID:
25625343
49.

[2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism].

Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw rozpoznawania i postepowania w ostrej zatorowości płucnej, Konstantinides S, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman M, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svítil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M.

Kardiol Pol. 2014;72(11):997-1053. doi: 10.5603/KP.2014.0211. Polish. No abstract available.

PMID:
25524375
50.

Effect of macitentan on hospitalizations: results from the SERAPHIN trial.

Channick RN, Delcroix M, Ghofrani HA, Hunsche E, Jansa P, Le Brun FO, Mehta S, Pulido T, Rubin LJ, Sastry BK, Simonneau G, Sitbon O, Souza R, Torbicki A, Galiè N.

JACC Heart Fail. 2015 Jan;3(1):1-8. doi: 10.1016/j.jchf.2014.07.013. Epub 2014 Nov 11.

Supplemental Content

Loading ...
Support Center